MedPath

Effect of Takrarishta on Irritable Bowl Syndrome

Not Applicable
Completed
Conditions
Health Condition 1: K582- Mixed irritable bowel syndrome
Registration Number
CTRI/2024/05/067261
Lead Sponsor
Bhimashankar Ayurved College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
12
Inclusion Criteria

1) Any gender

2) Any age range 21 and 50

3) Patient in a raw experiencing the primary symptoms of abdominal pain, flatulence, alterated bowel habit, change in frequency of bowel

4) individuals who exhibit the following symptoms: Mandagni and Mrudu Kosht

Exclusion Criteria

1) the participant lack of consent to continue their participation in study

2) Identification of any known gastrointestinal condition such as cancer hepatic failure IBD and renal insuffieucency

3) Patient incapacity to complete all study phases ,age under 18

4) pregnent women,

5) chronic history of medication

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the efficacy of Takrarishta in the stool culture and  sensitivity of colony count reduction in IBS patients. <br/ ><br>Timepoint: 14 days
Secondary Outcome Measures
NameTimeMethod
Adverse effect or any event of takrarishta on Irritable Bowl SyndromeTimepoint: 14 days
© Copyright 2025. All Rights Reserved by MedPath